PDB Short entry for 3QMK HEADER CELL ADHESION 04-FEB-11 3QMK TITLE CRYSTAL STRUCTURE OF THE E2 DOMAIN OF APLP1 IN COMPLEX WITH HEPARIN TITLE 2 HEXASACCHARIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID-LIKE PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: APLP1 E2 DOMAIN; COMPND 5 SYNONYM: APLP, APLP-1, C30; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: APLP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS APP, ALZHEIMER'S DISEASE, CELLULAR ADHESION, HEPARIN, BRAIN, CELL KEYWDS 2 ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,Y.HA REVDAT 3 21-FEB-24 3QMK 1 HETSYN REVDAT 2 29-JUL-20 3QMK 1 COMPND REMARK SEQADV HETNAM REVDAT 2 2 1 LINK SITE ATOM REVDAT 1 12-OCT-11 3QMK 0 JRNL AUTH Y.XUE,S.LEE,Y.HA JRNL TITL CRYSTAL STRUCTURE OF AMYLOID PRECURSOR-LIKE PROTEIN 1 AND JRNL TITL 2 HEPARIN COMPLEX SUGGESTS A DUAL ROLE OF HEPARIN IN E2 JRNL TITL 3 DIMERIZATION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 16229 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 21930949 JRNL DOI 10.1073/PNAS.1103407108 REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 24135 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2684 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.21 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.27 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1270 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE : 0.3200 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2995 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 275 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.64000 REMARK 3 B22 (A**2) : 1.25000 REMARK 3 B33 (A**2) : 0.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3QMK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000063833. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27708 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 3350, 0.1 M BIS-TRIS, 0.2 M REMARK 280 LI2SO4, 25 MM ATP, PH 6.5, MICROBATCH, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.09150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.39500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.94950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.39500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.09150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.94950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 281 REMARK 465 SER A 282 REMARK 465 HIS A 283 REMARK 465 MET A 284 REMARK 465 THR A 285 REMARK 465 PRO A 286 REMARK 465 THR A 287 REMARK 465 PRO A 288 REMARK 465 ARG A 289 REMARK 465 PRO A 290 REMARK 465 THR A 291 REMARK 465 SER A 487 REMARK 465 GLU A 488 REMARK 465 HIS A 489 REMARK 465 LEU A 490 REMARK 465 GLY A 491 REMARK 465 PRO A 492 REMARK 465 SER A 493 REMARK 465 GLU A 494 REMARK 465 GLY B 281 REMARK 465 SER B 282 REMARK 465 HIS B 283 REMARK 465 MET B 284 REMARK 465 THR B 285 REMARK 465 PRO B 286 REMARK 465 THR B 287 REMARK 465 PRO B 288 REMARK 465 ARG B 289 REMARK 465 PRO B 290 REMARK 465 THR B 291 REMARK 465 GLU B 488 REMARK 465 HIS B 489 REMARK 465 LEU B 490 REMARK 465 GLY B 491 REMARK 465 PRO B 492 REMARK 465 SER B 493 REMARK 465 GLU B 494 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 ARG A 330 CG CD NE CZ NH1 NH2 REMARK 470 MET A 334 CG SD CE REMARK 470 LYS A 340 CG CD CE NZ REMARK 470 ASN A 341 CG OD1 ND2 REMARK 470 LEU A 342 CG CD1 CD2 REMARK 470 LYS A 344 CG CD CE NZ REMARK 470 LEU A 350 CG CD1 CD2 REMARK 470 GLU A 352 CG CD OE1 OE2 REMARK 470 ASP A 402 CG OD1 OD2 REMARK 470 GLN A 405 CG CD OE1 NE2 REMARK 470 GLU A 407 CG CD OE1 OE2 REMARK 470 ARG A 414 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 415 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 440 CG CD OE1 OE2 REMARK 470 LYS A 441 CG CD CE NZ REMARK 470 GLN A 444 CG CD OE1 NE2 REMARK 470 GLU A 458 CG CD OE1 OE2 REMARK 470 GLN A 469 CG CD OE1 NE2 REMARK 470 HIS A 472 CG ND1 CD2 CE1 NE2 REMARK 470 LEU A 473 CG CD1 CD2 REMARK 470 GLN A 475 CG CD OE1 NE2 REMARK 470 GLU A 476 CG CD OE1 OE2 REMARK 470 ARG A 478 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 481 CG1 CG2 CD1 REMARK 470 GLN A 482 CG CD OE1 NE2 REMARK 470 GLU A 483 CG CD OE1 OE2 REMARK 470 LEU A 485 CG CD1 CD2 REMARK 470 HIS A 486 CG ND1 CD2 CE1 NE2 REMARK 470 ASP B 292 CG OD1 OD2 REMARK 470 ARG B 312 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 323 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 327 CG CD OE1 OE2 REMARK 470 MET B 334 CG SD CE REMARK 470 LYS B 340 CG CD CE NZ REMARK 470 ASN B 341 CG OD1 ND2 REMARK 470 LYS B 344 CG CD CE NZ REMARK 470 GLU B 374 CG CD OE1 OE2 REMARK 470 LEU B 383 CG CD1 CD2 REMARK 470 ASP B 402 CG OD1 OD2 REMARK 470 GLU B 407 CG CD OE1 OE2 REMARK 470 ARG B 408 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 421 CG CD OE1 NE2 REMARK 470 GLU B 440 CG CD OE1 OE2 REMARK 470 LYS B 441 CG CD CE NZ REMARK 470 GLU B 457 CD OE1 OE2 REMARK 470 GLN B 469 CG CD OE1 NE2 REMARK 470 ASN B 470 CG OD1 ND2 REMARK 470 HIS B 472 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 475 CG CD OE1 NE2 REMARK 470 ARG B 478 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 483 CG CD OE1 OE2 REMARK 470 HIS B 486 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 341 61.98 -108.53 REMARK 500 ASP A 402 -77.83 -7.63 REMARK 500 ASP A 438 75.21 -172.88 REMARK 500 LEU A 485 -34.38 -33.66 REMARK 500 PRO B 404 109.97 -47.22 REMARK 500 ASP B 438 73.20 -150.94 REMARK 500 ASN B 470 76.44 -150.93 REMARK 500 REMARK 500 REMARK: NULL DBREF 3QMK A 285 494 UNP P51693 APLP1_HUMAN 285 494 DBREF 3QMK B 285 494 UNP P51693 APLP1_HUMAN 285 494 SEQADV 3QMK GLY A 281 UNP P51693 EXPRESSION TAG SEQADV 3QMK SER A 282 UNP P51693 EXPRESSION TAG SEQADV 3QMK HIS A 283 UNP P51693 EXPRESSION TAG SEQADV 3QMK MET A 284 UNP P51693 EXPRESSION TAG SEQADV 3QMK GLY B 281 UNP P51693 EXPRESSION TAG SEQADV 3QMK SER B 282 UNP P51693 EXPRESSION TAG SEQADV 3QMK HIS B 283 UNP P51693 EXPRESSION TAG SEQADV 3QMK MET B 284 UNP P51693 EXPRESSION TAG SEQRES 1 A 214 GLY SER HIS MET THR PRO THR PRO ARG PRO THR ASP GLY SEQRES 2 A 214 VAL ASP ILE TYR PHE GLY MET PRO GLY GLU ILE SER GLU SEQRES 3 A 214 HIS GLU GLY PHE LEU ARG ALA LYS MET ASP LEU GLU GLU SEQRES 4 A 214 ARG ARG MET ARG GLN ILE ASN GLU VAL MET ARG GLU TRP SEQRES 5 A 214 ALA MET ALA ASP ASN GLN SER LYS ASN LEU PRO LYS ALA SEQRES 6 A 214 ASP ARG GLN ALA LEU ASN GLU HIS PHE GLN SER ILE LEU SEQRES 7 A 214 GLN THR LEU GLU GLU GLN VAL SER GLY GLU ARG GLN ARG SEQRES 8 A 214 LEU VAL GLU THR HIS ALA THR ARG VAL ILE ALA LEU ILE SEQRES 9 A 214 ASN ASP GLN ARG ARG ALA ALA LEU GLU GLY PHE LEU ALA SEQRES 10 A 214 ALA LEU GLN ALA ASP PRO PRO GLN ALA GLU ARG VAL LEU SEQRES 11 A 214 LEU ALA LEU ARG ARG TYR LEU ARG ALA GLU GLN LYS GLU SEQRES 12 A 214 GLN ARG HIS THR LEU ARG HIS TYR GLN HIS VAL ALA ALA SEQRES 13 A 214 VAL ASP PRO GLU LYS ALA GLN GLN MET ARG PHE GLN VAL SEQRES 14 A 214 HIS THR HIS LEU GLN VAL ILE GLU GLU ARG VAL ASN GLN SEQRES 15 A 214 SER LEU GLY LEU LEU ASP GLN ASN PRO HIS LEU ALA GLN SEQRES 16 A 214 GLU LEU ARG PRO GLN ILE GLN GLU LEU LEU HIS SER GLU SEQRES 17 A 214 HIS LEU GLY PRO SER GLU SEQRES 1 B 214 GLY SER HIS MET THR PRO THR PRO ARG PRO THR ASP GLY SEQRES 2 B 214 VAL ASP ILE TYR PHE GLY MET PRO GLY GLU ILE SER GLU SEQRES 3 B 214 HIS GLU GLY PHE LEU ARG ALA LYS MET ASP LEU GLU GLU SEQRES 4 B 214 ARG ARG MET ARG GLN ILE ASN GLU VAL MET ARG GLU TRP SEQRES 5 B 214 ALA MET ALA ASP ASN GLN SER LYS ASN LEU PRO LYS ALA SEQRES 6 B 214 ASP ARG GLN ALA LEU ASN GLU HIS PHE GLN SER ILE LEU SEQRES 7 B 214 GLN THR LEU GLU GLU GLN VAL SER GLY GLU ARG GLN ARG SEQRES 8 B 214 LEU VAL GLU THR HIS ALA THR ARG VAL ILE ALA LEU ILE SEQRES 9 B 214 ASN ASP GLN ARG ARG ALA ALA LEU GLU GLY PHE LEU ALA SEQRES 10 B 214 ALA LEU GLN ALA ASP PRO PRO GLN ALA GLU ARG VAL LEU SEQRES 11 B 214 LEU ALA LEU ARG ARG TYR LEU ARG ALA GLU GLN LYS GLU SEQRES 12 B 214 GLN ARG HIS THR LEU ARG HIS TYR GLN HIS VAL ALA ALA SEQRES 13 B 214 VAL ASP PRO GLU LYS ALA GLN GLN MET ARG PHE GLN VAL SEQRES 14 B 214 HIS THR HIS LEU GLN VAL ILE GLU GLU ARG VAL ASN GLN SEQRES 15 B 214 SER LEU GLY LEU LEU ASP GLN ASN PRO HIS LEU ALA GLN SEQRES 16 B 214 GLU LEU ARG PRO GLN ILE GLN GLU LEU LEU HIS SER GLU SEQRES 17 B 214 HIS LEU GLY PRO SER GLU HET SGN C 1 20 HET IDS C 2 16 HET SGN C 3 19 HET IDS C 4 16 HET SO4 B 1 5 HET SO4 B 2 5 HET SO4 B 3 5 HETNAM SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D-GLUCOPYRANOSE HETNAM IDS 2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID HETNAM SO4 SULFATE ION HETSYN SGN N,O6-DISULFO-GLUCOSAMINE; 6-O-SULFO-N-SULFO-ALPHA-D- HETSYN 2 SGN GLUCOSAMINE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D- HETSYN 3 SGN GLUCOSE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-D-GLUCOSE; HETSYN 4 SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-GLUCOSE HETSYN IDS O2-SULFO-GLUCURONIC ACID; 2-O-SULFO-ALPHA-L-IDURONIC HETSYN 2 IDS ACID; 2-O-SULFO-L-IDURONIC ACID; 2-O-SULFO-IDURONIC HETSYN 3 IDS ACID FORMUL 3 SGN 2(C6 H13 N O11 S2) FORMUL 3 IDS 2(C6 H10 O10 S) FORMUL 4 SO4 3(O4 S 2-) FORMUL 7 HOH *275(H2 O) HELIX 1 1 ASP A 292 GLY A 299 1 8 HELIX 2 2 SER A 305 GLN A 338 1 34 HELIX 3 3 PRO A 343 GLN A 400 1 58 HELIX 4 4 GLN A 405 ASP A 438 1 34 HELIX 5 5 ASP A 438 GLN A 444 1 7 HELIX 6 6 MET A 445 GLN A 469 1 25 HELIX 7 7 ASN A 470 LEU A 485 1 16 HELIX 8 8 ASP B 292 GLY B 299 1 8 HELIX 9 9 SER B 305 SER B 339 1 35 HELIX 10 10 PRO B 343 GLN B 400 1 58 HELIX 11 11 GLN B 405 ASP B 438 1 34 HELIX 12 12 ASP B 438 LEU B 466 1 29 HELIX 13 13 LEU B 467 GLN B 469 5 3 HELIX 14 14 ASN B 470 SER B 487 1 18 LINK O4 SGN C 1 C1 IDS C 2 1555 1555 1.40 LINK O4 IDS C 2 C1 SGN C 3 1555 1555 1.39 LINK O4 SGN C 3 C1 IDS C 4 1555 1555 1.40 CRYST1 74.183 81.899 90.790 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013480 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012210 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011014 0.00000